Clinical Trial Update: Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating alfacalcidol's effect on respiratory infection and immune response in frail elderly individuals, with uncertain status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elderly Infection
• Frail Elderly Syndrome

Drugs mentioned

• Alfacalcidol (alfacalcidol)

Snippet

Sponsor: Indonesia University | Conditions: Frail Elderly Syndrome, Elderly Infection | Phase 4 | Status: UNKNOWN